MALVERN, Pa., June 10, 2024 /PRNewswire/ -- Endo, Inc. announced today the launch of its newest television commercial and disease awareness campaign, Reminders. The campaign empowers patients to advocate for their preferred treatment plan for Dupuytren's contracture, a progressive hand condition that affects an estimated 17 million Americans.
MALVERN, Pa., May 7, 2024 /PRNewswire/ -- Endo, Inc. announced today that three new presentations related to Peyronie's disease and XIAFLEX® (collagenase clostridium histolyticum) were shared during the American Urological Association (AUA) annual meeting, which took place May 3-6, 2024. Endo supported development of these data by providing funding through investigator-initiated research grants.
Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
Endo Reports Fourth-Quarter 2023 Financial Results